Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram De Wilde

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Clinical Epigenetics|July 5, 2024
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluidLotte Cornelli, Ruben Van Paemel, Maísa R Ferro Dos Santos, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Targeted AURKA degradation: Towards new therapeutic agents for neuroblastomaMuhammad Rishfi, Simon Krols, Fien Martens, et al.
European Journal of Pediatrics|January 4, 2020
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a reviewRuben Van Paemel, Roos Vlug, Katleen De Preter, et al.
Nature|March 12, 2025
Author Correction: Classification with a disordered dopant atom network in siliconTao Chen, Jeroen van Gelder, Bram van de Ven, et al.
European Journal of Pediatrics|May 25, 2020
Correction to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as reviewRuben Van Paemel, Roos Vlug, Katleen De Preter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma PatientsNadine Van Roy, Malaïka Van Der Linden, Björn Menten, et al.
Nature|January 17, 2020
Classification with a disordered dopant-atom network in siliconTao Chen, Jeroen van Gelder, Bram van de Ven, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Clinical Epigenetics|July 5, 2024
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluidLotte Cornelli, Ruben Van Paemel, Maísa R Ferro Dos Santos, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Targeted AURKA degradation: Towards new therapeutic agents for neuroblastomaMuhammad Rishfi, Simon Krols, Fien Martens, et al.
European Journal of Pediatrics|January 4, 2020
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a reviewRuben Van Paemel, Roos Vlug, Katleen De Preter, et al.
Nature|March 12, 2025
Author Correction: Classification with a disordered dopant atom network in siliconTao Chen, Jeroen van Gelder, Bram van de Ven, et al.
European Journal of Pediatrics|May 25, 2020
Correction to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as reviewRuben Van Paemel, Roos Vlug, Katleen De Preter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma PatientsNadine Van Roy, Malaïka Van Der Linden, Björn Menten, et al.
Nature|January 17, 2020
Classification with a disordered dopant-atom network in siliconTao Chen, Jeroen van Gelder, Bram van de Ven, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pageof 7